
Insights from Bayer’s $1.5 Billion VC Fund | Lucio Iannone, Head of Health Venture Investments (VP) at Leaps by Bayer
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
Leaps by Bayer's Bold Investment Model
Jess asks how Leaps differs from typical corporate VC; Lucio explains Leaps' mission, large early checks, and strategic acquisitions like BlueRock.
Transcript
Play full episode